Exec Director, Asset Team Leader
Scorpion Therapeutics, San Francisco, California, United States, 94199
Role Summary
Exec Director, Asset Team Leader will lead teams covering multiple HIV-related assets across early- to late-phase and marketed products. The role involves developing and executing cohesive asset strategies, enabling cross-functional collaboration, and guiding portfolio governance and decision-making to deliver program milestones. This position requires strong leadership to align global teams, manage complex programs, and communicate effectively with senior leadership. Responsibilities
Strategic Asset Leadership: Lead asset teams in developing and executing cohesive asset and program strategies, aligning with broader organizational goals through resource assessment, timeline management, and risk mitigation. Cross-functional Collaboration: Enable strong collaboration around a shared asset vision, ensuring transparent flow of asset-related information and decisions across teams and partners. Accountability for Delivery: Ensure timely achievement of key asset milestones; monitor progress against the Target Product Profile (TPP), Asset Plan, and Lifecycle Plan (LCP) with respect to timelines and budgets. Integrated Strategy Development: Develop and present global asset strategies spanning product development, manufacturing, commercialization and lifecycle management, adapting plans as clinical, regulatory, or commercial landscapes evolve. Governance and Decision Facilitation: Facilitate decisions with cross-functional insights, drive scenario planning and risk analysis, and communicate with senior leadership and governance bodies; set Go/No Go decision points and present data to Portfolio Committee. Team Leadership: Align cross-functional teams around a unified asset vision, foster clear roles and accountability, and cultivate a high-performing, inclusive and collaborative team environment. Stakeholder Engagement: Build and maintain strong relationships with internal and external partners to support program success and innovation. Operational Excellence: Ensure excellence in operationalization of integrated asset strategy and stakeholder activities to deliver program milestones. Scientific and Medical Advocacy: Articulate and champion asset strategies, scientific rationale, and clinical objectives to diverse audiences. Portfolio and Therapeutic Area Strategy: Advise on disease area strategies for discovery, innovation, development, and lifecycle planning in collaboration with Therapeutic Area Leaders and Business Development. Qualifications
Advanced scientific, medical, or commercial background with expertise in drug development and relevant therapeutic areas; proven ability to make complex decisions with an enterprise perspective. Demonstrated cross-functional leadership across global initiatives, effectively managing projects and executing strategic plans. Proven ability to lead multidisciplinary teams and integrate discovery, development, regulatory, and commercial considerations across all asset lifecycle phases. Able to lead, influence, and deliver significant impact even in the absence of direct authority. Exceptional communication, organizational, and decision-making skills, able to resolve complex issues and influence senior leaders. Track record of high-level performance and strategic value delivery within global pharmaceutical or biotech organizations. Comprehensive understanding of the drug development process, including full asset lifecycle management and end-to-end brand exposure. Education
Bachelor’s degree in a scientific or business discipline required; advanced degrees such as PhD, MD, or MBA highly preferred. For some GATL roles, an MD or PhD may be prioritized. 12+ years’ biopharmaceutical industry experience preferred, with at least 8 years in relevant roles within biotech/pharmaceutical organizations. Comprehensive knowledge of the overall drug development process, with experience in commercial launches and program/asset strategy teams strongly desired. Minimum Experience requirements for Executive Director Level: 16+ with BS; 14+ MS or PhD; 8+ years with MD.
#J-18808-Ljbffr
Exec Director, Asset Team Leader will lead teams covering multiple HIV-related assets across early- to late-phase and marketed products. The role involves developing and executing cohesive asset strategies, enabling cross-functional collaboration, and guiding portfolio governance and decision-making to deliver program milestones. This position requires strong leadership to align global teams, manage complex programs, and communicate effectively with senior leadership. Responsibilities
Strategic Asset Leadership: Lead asset teams in developing and executing cohesive asset and program strategies, aligning with broader organizational goals through resource assessment, timeline management, and risk mitigation. Cross-functional Collaboration: Enable strong collaboration around a shared asset vision, ensuring transparent flow of asset-related information and decisions across teams and partners. Accountability for Delivery: Ensure timely achievement of key asset milestones; monitor progress against the Target Product Profile (TPP), Asset Plan, and Lifecycle Plan (LCP) with respect to timelines and budgets. Integrated Strategy Development: Develop and present global asset strategies spanning product development, manufacturing, commercialization and lifecycle management, adapting plans as clinical, regulatory, or commercial landscapes evolve. Governance and Decision Facilitation: Facilitate decisions with cross-functional insights, drive scenario planning and risk analysis, and communicate with senior leadership and governance bodies; set Go/No Go decision points and present data to Portfolio Committee. Team Leadership: Align cross-functional teams around a unified asset vision, foster clear roles and accountability, and cultivate a high-performing, inclusive and collaborative team environment. Stakeholder Engagement: Build and maintain strong relationships with internal and external partners to support program success and innovation. Operational Excellence: Ensure excellence in operationalization of integrated asset strategy and stakeholder activities to deliver program milestones. Scientific and Medical Advocacy: Articulate and champion asset strategies, scientific rationale, and clinical objectives to diverse audiences. Portfolio and Therapeutic Area Strategy: Advise on disease area strategies for discovery, innovation, development, and lifecycle planning in collaboration with Therapeutic Area Leaders and Business Development. Qualifications
Advanced scientific, medical, or commercial background with expertise in drug development and relevant therapeutic areas; proven ability to make complex decisions with an enterprise perspective. Demonstrated cross-functional leadership across global initiatives, effectively managing projects and executing strategic plans. Proven ability to lead multidisciplinary teams and integrate discovery, development, regulatory, and commercial considerations across all asset lifecycle phases. Able to lead, influence, and deliver significant impact even in the absence of direct authority. Exceptional communication, organizational, and decision-making skills, able to resolve complex issues and influence senior leaders. Track record of high-level performance and strategic value delivery within global pharmaceutical or biotech organizations. Comprehensive understanding of the drug development process, including full asset lifecycle management and end-to-end brand exposure. Education
Bachelor’s degree in a scientific or business discipline required; advanced degrees such as PhD, MD, or MBA highly preferred. For some GATL roles, an MD or PhD may be prioritized. 12+ years’ biopharmaceutical industry experience preferred, with at least 8 years in relevant roles within biotech/pharmaceutical organizations. Comprehensive knowledge of the overall drug development process, with experience in commercial launches and program/asset strategy teams strongly desired. Minimum Experience requirements for Executive Director Level: 16+ with BS; 14+ MS or PhD; 8+ years with MD.
#J-18808-Ljbffr